IL6 and chronic kidney disease: For example, in chronic kidney disease (CKD), the increased expression of GPR68 on human monocytes promotes the release of TNF-α, IL-6, and other pro-inflammatory cytokines, which aggravate systemic inflammation and fibrosis (Sarakpi et al., 2023).